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Abstract Interdomain interactions play an important role in
the structural organization of many enzymes and the conforma-
tional flexibility of their molecules. In this review, the role of
intrasubunit and intersubunit domain^domain interactions in the
origins of pre-existent asymmetry of homo-oligomeric D-
glyceraldehyde-3-phosphate dehydrogenase and tryptophanyl-
tRNA synthetase is discussed on the basis of recent X-ray data
and other available information about the properties of these and
related enzymes. In addition, a novel key function of interdomain
interactions is considered : their potential contribution to
intramolecular channeling of intermediates between active
centers located on different subunits of a hetero-oligomeric
enzyme (K,L-heterodimeric carbamoyl phosphate synthe-
tase). ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
It has long been recognized that proteins exhibit a molec-
ular architecture consisting of globular and compact substruc-
tures (structural domains) that may be autonomous folding
units [1^3].
Rossmann and Liljas were the ¢rst to demonstrate that
di¡erent domains of some proteins have di¡erent functions
(e.g. NAD-binding and catalytic functions in a number of
dehydrogenases [4]). Since that time, a large body of structural
information has accumulated on multidomain enzymes. It be-
came clear that one of the most important consequences of a
monomer’s multidomain organization is that the active center
is typically located at the interface between the domains,
which provides the structural £exibility needed for the enzyme
to function. The binding of a substrate to one of the domains
induces appreciable (sometimes large-scale) structural
changes, which involve domain displacements and result in
the closure of the interdomain cleft to shield the substrate
from water by surrounding it with catalytic residues [5]. Con-
sequently, domain motions provide a mechanism by which the
induced ¢t phenomenon described by Koshland [6] can be
accomplished. Structural mechanisms for domain motions in
proteins are delineated and analyzed in the excellent review by
Gerstein et al. [7].
Association of identical monomers into oligomers consider-
ably increases the complexity of the system of interdomain
interactions: in addition to intrasubunit interactions involved
in the formation of the active center of each monomer, inter-
subunit contacts arise between domains belonging to di¡erent
monomers. In this way, a certain region of each domain be-
comes involved in the formation of the active center, whereas
another region provides the basis for contact with the neigh-
boring monomer. This is rather important given the nature of
domains as relatively independent globular structures which
are able to change conformation cooperatively and to move
around as ‘rigid bodies’ [7]. Thus, a movement of a domain
induced, for instance, by the binding of substrate in the active
center, may in a certain way a¡ect the intersubunit contact
region. On the other hand, even minor changes in the inter-
subunit contact area formed by domains may bring about
signi¢cant alterations in the active centers which are formed
at the interface between other regions of the same domains.
This creates the structural basis for a stringent correlation
between the state of intersubunit contacts in an oligomer
and the functional state of the active centers.
In the case of homo-oligomers, the above e¡ect may man-
ifest itself, for example, in the interconversion between the
symmetric and asymmetric states of the macromolecule : the
active centers may become conformationally non-equivalent.
In the ¢rst part of the present review, data on three cases of
pre-existing asymmetry of homo-oligomers are summarized
and an attempt is made to characterize the molecular mecha-
nisms underlying the manifestation of this property. The sec-
ond part focuses on the functional consequences of interdo-
main interactions in a hetero-oligomeric enzyme, in order to
highlight a role played by domain movements in the channel-
ing of intermediates between active centers located at consid-
erable distances from each other in the enzyme molecule.
2. Homo-oligomers
2.1. D-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
Despite the fact that this tetrameric enzyme is composed of
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chemically identical subunits, and all its active centers are
equivalent in terms of catalyzing the physiological reaction,
under certain conditions (reaction with bulky substrate ana-
logs or modi¢cation of the essential cysteine residues by some
reagents) the active centers exhibit a pairwise non-equivalence
(half-of-the-sites reactivity). Another characteristic property
of GAPDH isolated from many sources is negative coopera-
tivity upon binding of the coenzyme [8^12]. To explain this
behavior, Bernhard, MacQuarrie and Seydoux [8,9] have of-
fered the pre-existing asymmetry model, whereby the holo-
tetramer exists in an equilibrium between the symmetric and
the asymmetric forms, which can be shifted towards the asym-
metric form by the binding of a speci¢c ligand. An alternative
model elaborated by Koshland et al. was based on the as-
sumption that asymmetry could be induced upon substrate-
binding to the holo-form which is symmetric [10].
Long-term experimental studies performed in succeeding
years have yielded a considerable body of information on
subunit non-equivalence in GAPDH [13^20], but the principal
question concerning the structural basis of this phenomenon
remained unanswered. It was not su⁄ciently clari¢ed even by
a direct crystallographic demonstration of molecular asymme-
try in an abortive ternary complex, in which a lobster muscle
GAPDH^NAD complex was covalently linked with the sub-
strate analog, 3,3,3-tri£uorobromoacetone [21]. The results
did not lend themselves to an unambiguous interpretation in
view of the possibility that the asymmetry might have been a
ligand-induced e¡ect.
One of the ¢rst demonstrations of pre-existent asymmetry
of the apo-GAPDH observed with the physiological substrate
was obtained in the studies by our laboratory, which showed
that selective chemical modi¢cation of Arg 231 in all four
active centers of rabbit muscle GAPDH stabilizes the tetramer
in the asymmetric state where only two active centers are able
to catalyze the physiological reaction, albeit with lower activ-
ity (about 5% of the activity of the unmodi¢ed enzyme)
[22,23]. Since all four arginine residues had been equally ac-
cessible to modi¢cation, one could assume that the observed
asymmetry had not been induced by the attachment of the
modifying agent, but resulted from the stabilization of one
of the pre-existing states of the apoenzyme. Evidence was
also obtained that stabilization of GAPDH in the asymmetric
state does not a¡ect the NAD-binding properties of the en-
zyme, and the half-of-the-sites reactivity and negative cooper-
ativity in the binding of NAD are therefore probably gener-
ated by di¡erent mechanisms [24].
The similarity of results obtained with GAPDHs from dif-
ferent sources (rabbit muscle and Escherichia coli [25,26]) has
made it possible to analyze them on the basis of structural
information available for GAPDH from E. coli [27]. Fig. 1
shows the structural elements of the GAPDH monomer in-
volved in contacts between the NAD-binding domain (resi-
dues 1^147, as well as the C-terminal K3 helix), and the cata-
lytic domain (residues 149^311). It is seen that interdomain
interactions of the ‘intrasubunit’ type are largely due to hy-
drogen bonds between amino acid residues which are constit-
uents of the K3 helix of the coenzyme-binding domain, on the
one hand, and of the loop 275^290 of the catalytical domain,
on the other. Of considerable importance for the formation of
the active center (which incorporates Cys 149, His 176, Arg
231 and several other residues) is a network of interactions
developed by Asp 312 and Asn 313 with a group of amino
acid residues located in the L-strands L1, L2 and L3 or nearby
(Asn 236, Val 237, Ser 238). All these residues are strictly
conservative.
Furthermore, the ¢gure shows that another part of the
NAD-binding domain, i.e. the KC helix and the loop con-
nected to it, is also involved in contacts with the catalytic
domain, but in this case the contacts are of the ‘intersubunit’
type, namely between the coenzyme-binding domain of one
subunit and the catalytic domain of the other. Filled triangles
mark the amino acid residues involved in intersubunit con-
tacts of the r type. It is seen that the hydrogen bonds in this
contact region are formed almost exclusively between amino
acid residues located in the NAD-binding domain of one sub-
unit and in the so-called S-loop (residues 177^201) of the
catalytic domain belonging to the neighboring subunit. This
deserves particular attention because the amino acid sequence
of the S-loop is one of the less conservative regions in the
polypeptide chain and varies signi¢cantly in GAPDHs from
di¡erent sources. Thus, even though the three-dimensional
structure of E. coli GAPDH is very close to that of GAPDH
from Bacillus stearothermophilus [29], the S-loops of these two
enzymes contain very dissimilar amino acid sequences [30].
In GAPDH from B. stearothermophilus, the character of the
amino acid sequence in the region of residues 187^191 pre-
cludes the formation of a hydrogen bond between Arg 231
and Asp 192 in any of the four subunits of the tetramer. In all
of them, Arg 231 is hydrogen-bonded to Thr 179. On the
other hand, the E. coli GAPDH subunits are non-equivalent:
two of them (the so-called O and Q subunits) can form a
hydrogen bond in two alternative ways: either Arg 231^Thr
179 or Arg 231^Asp 192 [27]. In the ¢rst case, all four sub-
units become conformationally identical, and the symmetric
tetramer is formed. In the second case, the asymmetric struc-
ture is stabilized. These structural data provide an explanation
of why chemical modi¢cation of Arg 231 locked the tetramer
in a state where only two of the four active centers became
accessible to the physiological substrate, glyceraldehyde-3-
phosphate [22^26]. This might occur owing to stabilization
of one of the two alternative conformational states of the
tetramer, the asymmetric one, with di¡erent environment of
the arginine in the two pairs of subunits.
A question arises as to whether the ability of the oligomer
to exist in an equilibrium between the symmetric and the
asymmetric states has any functional signi¢cance. At the
present level of our knowledge, no de¢nite answer can be
given yet. Under steady-state conditions, all four active cen-
ters of the E. coli GAPDH are catalytically equivalent, which
suggests that the binding of glyceraldehyde-3-phosphate shifts
the equilibrium towards the symmetric state. On the other
hand, some observations apparently indicate that a switching
from ‘all-of-the-sites’ to ‘half-of-the-sites’ activity may occur
under speci¢c conditions [16]. A hypothetical possibility also
exists that stabilization of the tetramer in the asymmetric state
might serve as a mechanism regulating the number of simul-
taneously functioning active centers.
2.2. Homo-oligomeric aminoacyl-tRNA synthetases
2.2.1. Tryptophanyl-tRNA synthetase (TrpRS) from B.
stearothermophilus. This enzyme, catalyzing tryptophan acti-
vation by ATP with subsequent aminoacylation of tRNATrp,
belongs to the class I of aminoacyl-tRNA synthetases [31].
The N-terminal domain (V200 residues) of the enzyme mol-
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ecule contains TIGN and KMSKS sequence motifs which
occur at each end of a supersecondary structure called the
Rossmann fold, but are brought close to each other in the
tertiary structure by a pronounced twist of the four-stranded
parallel L-sheet, to form much of the adenine^nucleotide bind-
ing site [32]. The second domain is a small four-helix bundle
of about 95 residues containing a putative binding site for the
tRNATrp anticodon.
The recent solving of the tertiary structure of this enzyme in
the absence of ligands [33] and a comparison of the data
obtained with the results of a study of the TrpRS^tryptophan-
yl-5P AMP complex [34] have made it possible to reveal an
important role played by the movements and rearrangements
of various domains in the process of organization of di¡erent
regions of the active site. Thus, it was established that unex-
pected rearrangements occur in the structure of the nucleo-
tide-binding fold, giving rise to various new kinds of interdo-
main interactions: the amino-terminal KA helix, the TIGN
and KMSK sequences, together with the distal helical domain
rotate as a single rigid body away from what remains of the
Rossmann fold, opening the AMP-binding site, seen in the
TrpRS^tryptophanyl-5P AMP complex [34], into two halves.
In this way, a new form of the C-terminal domain is created;
the functional boundary between this domain and the N-ter-
minal domain (lacking the KA) now lies within the Rossmann
fold domain itself. As particularly emphasized by the authors
[33], the small domain de¢ned by the domain motion contains
both TIGN and KMSKS sequences, which have been shown
to interact with the ribose and pyrophosphate moieties in the
transition state of the tyrosine activation by TyrRS [35,36],
and are therefore of central importance to the catalysis of
amino acid activation.
Another interesting result obtained in the structural study
of TrpRS in the absence of ligands was the ¢nding that, un-
like the TrpRS^tryptophanyl-5P AMP complex, which is a
symmetric dimer [34], in the absence of ligands the dimer
becomes asymmetric. The small domain assumes a di¡erent
conformation in each monomer. It has been shown that di¡er-
Fig. 1. Fragments of the three-dimensional structure of GAPDH. Bold lines are used to draw the structural elements of the coenzyme-binding
domain, and thin lines, the structural elements of the catalytic domain. Filled circles mark the amino acid residues which form hydrogen bonds
between the domains inside a monomer of E. coli GAPDH. The hydrogen bonds are formed between amino acid residues 49 and 284, 146 and
152, 312 and 236, 312 and 285, 313 and 237, 313 and 238, 313 and 236, 316 and 286, 320 and 269, and 320 and 287. Filled triangles mark the
amino acid residues which form hydrogen bonds between neighboring subunits (contacts of the r type). These hydrogen bonds are formed be-
tween residues 13 and 186, 48 and 186, 39 and 189, 48 and 197, 42 and 197, 49 and 201, and 48 and 202. Two alternative possibilities of a hy-
drogen bond formation between Arg 231 and either Thr 179 or Asp 192 in E. coli GAPDH are also shown (see text for details). The picture
has been taken from [28], with alterations.
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ences between the monomers constituting the dimeric unit
result almost exclusively from variations in the interdomain
£exibilities exhibited during the outward motion of the small
domain relative to its con¢guration in the TrpRS^tryptophan-
yl-5P AMP complex. Thus, the angle vK subtended by the
centers of mass in the two domains in ligand-free TrpRS
and in the enzyme^tryptophanyl-5P AMP complex on the
axis around which they rotate is close to 14‡ in one monomer
but only about 11‡ in the other. The changes within the li-
gand-free asymmetric unit are limited to short segments be-
fore and after the KA helix (residues 3^17), and a longer seg-
ment at the end of the ¢nal L-strand in the Rossmmann fold
structure lacking the KA helix (residues 170^190).
The most remarkable fact is that the loop Arg 175^Ile 183
following the ¢nal L-sheet of the N-terminal domain, imme-
diately precedes the KMSKS sequence and is located at the
interface between the two domains. This suggests that inter-
domain motions accompanying the formation of the enzyme^
tryptophanyl-5P AMP complex might somewhat di¡er in the
monomers constituting the asymmetric dimer, thus creating
conformationally di¡erent active centers.
2.2.2. Tyrosyl-tRNA synthetase (TyrRS) from B.
stearothermophilus. The crystallographic studies demonstrat-
ing the pre-existent asymmetry of TrpRS are in excellent
agreement with the results of experiments performed on
TyrRS, an enzyme which is closely analogous to TrpRS
both structurally and functionally [31]. In this case, the asym-
metry showed itself in the half-of-the-sites reactivity exhibited
by the enzyme in solution: only 1 mol of tyrosine could be
bound and only 1 mol of tyrosyl-adenylate was formed per
two active sites. Furthermore, only 1 mol of tRNA was able
to bind to a dimer [37,38]. The results of these solution studies
appeared to contradict those of X-ray crystallography which
had shown the enzyme to be a symmetric dimer with an elec-
tron density allowing for 2 mol of tyrosine bound/mol of
dimer [39,40]. To reveal the structural basis of the asymmetry,
a series of elegant experiments were performed [41^43], dem-
onstrating clearly that pre-existing asymmetry had in fact
been the cause of the e¡ects observed. The experimental ap-
proach was based on the construction of heterodimers of
TyrRS containing one full-length subunit and one truncated
subunit (an isolated N-terminal domain). The absence of the
small C-terminal domain abolished the binding of tRNA to
the truncated subunit but left the kinetics of the activation
reaction (the formation of tyrosyl-adenylate) una¡ected. The
catalytic properties of the unmodi¢ed full-length and trun-
cated subunits in the activation reaction were identical. The
construction of heterodimers obtained from parental full-
length and truncated homodimers provided a way to ‘tag’
the individual subunits so that a mutation can be speci¢cally
introduced into one prede¢ned subunit. Two populations of
heterodimers were prepared. The dimers of one population
contained the His45Asn mutation introduced into the isolated
activation domain, whereas the dimers of the other population
contained the His45Asn mutation introduced into the activa-
tion domain within the full-length subunit.
The kinetics of the activation reaction performed by the
two populations of heterodimers were then measured with
the following results. 50% of heterodimers were found to be
active in one subunit, and 50% in the other. In the presence of
the substrates of the aminoacylation reaction, heterodimers
containing Asn 45 on one subunit formed the ¢rst 0.5 mol
of Tyr-AMP per mol of dimer rapidly, i.e. at the ‘wild-type’
rate (t1=2 = 20 ms), while the next 0.5 mol was formed four
orders of magnitude slower (t1=2 = 200 s, a rate expected for a
mutant). Had the half-of-the-sites activity been induced by the
formation of the ¢rst mol of tyrosyl-adenylate, the wild-type
site would have been the one occupied. Yet the experiment
showed that only 50% of the wild-type subunits had partici-
pated in the reaction, which means that the other 50% were
inaccessible to substrates under these conditions. In terms of
asymmetry, one should expect a random mix of active wild-
type subunit/inactive mutant and inactive wild-type site/active
mutant.
These results support the suggestion that pre-existent asym-
metry may be a common property of dimeric molecules in
both TrpRS and TyrRS. Considering the similarity in the
structural and functional properties of TrpRS and TyrRS,
one is tempted to suggest that the basic principles underlying
the development of dimer asymmetry might be similar in these
two enzymes. Further studies are needed to test the validity of
this proposal. At the same time, some progress has been made
towards understanding the rationale behind the functional
non-equivalence of TyrRS subunits associated in a dimer. De-
tailed kinetic analysis performed on heterodimers containing
di¡erent mutations in each subunit has shown that for e⁄-
cient catalysis to occur, two Tyr molecules must bind sequen-
tially to the same active site. It was suggested that the second
molecule of Tyr aids the dissociation of Tyr-tRNA by displac-
ing the tyrosyl moiety from its binding site [42]. The authors
also hypothesized that the functions of the catalytically inac-
tive subunit are to bind tRNA and possibly to stabilize the
active conformation of the dimer, since a monomeric enzyme
does not activate Tyr.
In sum, the several examples considered above illustrate
that an intriguing but poorly understood property of en-
zymes: the asymmetry which is intrinsic in the design of
some homo-oligomers, is now becoming the subject of thor-
ough structural analysis. From the data available, it might be
assumed that a pairwise asymmetry is a result of minor
changes in the character of interdomain interactions respon-
sible for the stabilization of the active center in a catalytically
competent conformation. One of the two subunits constituting
the asymmetric unit seems to be more £exible (perhaps more
unfolded) than the other, owing to the peculiarities of inter-
domain interactions of di¡erent types which determine the
£exibility of the enzyme structure. Considering that transition
between the symmetric and asymmetric states may turn out to
be one of the regulatory mechanisms in oligomeric enzymes,
the conditions under which it takes place and the factors
capable of inducing it probably merit future study.
3. Hetero-oligomers
3.1. Carbamoyl phosphate synthetase (CPS) from E. coli
As isolated from E. coli, this enzyme is an K,L-heterodimer.
The recently obtained crystallographic structure of CPS shows
clearly that the active site on the small subunit, and two other
active sites located on the large subunit are separated by
nearly 100 Aî in three-dimensional space [44]. The structural
investigation revealed the relative location of the three inde-
pendent active sites catalyzing the following reactions:
1. Hydrolysis of glutamine.
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2. Synthesis of carboxyphosphate and displacement of phos-
phate by ammonia to produce carbamate.
3. Phosphorylation of carbamate to liberate carbamoyl phos-
phate.
The two active sites contained within the large subunit and
catalyzing reactions 2 and 3 were found to be separated by a
linear distance of V35 Aî and connected by an intramolecular
tunnel that runs through the interior of the entire protein [45].
On the other hand, the small subunit forms molecular con-
tacts only with the N-terminal half of the large subunit. Fur-
thermore, the active site identi¢ed in the small subunit for
glutamine hydrolysis is V45 Aî away from site 2 on the large
subunit. Despite this, a direct transfer of ammonia from the
small subunit to the large one was demonstrated without its
appearance in solution [46]. These observations have raised
the possibility of coupled synthesis of carbamoyl phosphate
through the molecular tunnel from the small subunit to the
large one. In order for this process to work e⁄ciently, the
catalytic activities within the three active sites must be coor-
dinated with one another.
Experimental evidence has indeed been obtained for allo-
steric communication among the active sites [46]. Thus, the
rate constants for the formation and hydrolysis of the thio-
ester intermediate within the small subunit increase roughly
1000-fold when ATP is being hydrolyzed within the N-termi-
nal half of the large subunit. A conformational change must
therefore be transmitted from the large subunit to the small
one that serves to optimize the orientation of speci¢c active
site residues. On the other hand, when glutamine is hydro-
lyzed by the small subunit, the steady-state rate of ATP hy-
drolysis increases by about one order of magnitude. It appears
from these results that the phosphorylation of bicarbonate
within the carboxyphosphate unit acts as a ‘gate keeper’ for
the molecular tunnels in CPS. Only after the bicarbonate has
been phosphorylated does the hydrolysis of glutamine become
fast enough to inject a molecule of ammonia into the tunnel.
To explain the molecular mechanisms responsible for com-
munication between the active sites, it has been postulated
that they communicate via domain movements. This interest-
ing proposal has been supported lately by detailed studies into
the domain structure of the enzyme under di¡erent condi-
tions. Both carboxyphosphate and carbamoyl phosphate syn-
thase units were found to be composed of three domains: A,
B and C domains. The recently obtained results [47] provided
the ¢rst example of domain movement in CPS caused by the
binding of a nucleotide triphosphate. This movement, trig-
gered by hydrogen-bonding interactions between the L and Q
phosphates of the ATP analog and the backbone amino
groups, was accomplished by numerous small changes in the
dihedral angles of the polypeptide chain backbone. The
changes were propagated throughout one of the three do-
mains, the B domain, with some atoms moving more than
7.0 Aî . The whole body of information obtained by Thoden
et al. [47] suggests that correlated openings and closings of
these domains should in£uence both the catalytic activities of
the active sites in the large subunit and the movements of
substrates and products within this hetero-oligomeric enzyme.
Detailed elucidation of the mechanism of these e¡ects is of
particular interest in the context of understanding the princi-
ples which can be used by a protein molecule to ensure a
direct transfer of intermediates between di¡erent active cen-
ters.
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